Joung-Liang Lan - Division of Immunology and Rheumatology, China Medical University Hospital

基本信息

浏览量：83

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 242 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

OP0089 PHASE 2 SAFETY AND EFFICACY OF SUBCUTANEOUS (S.C.) DOSE IANALUMAB (VAY736; ANTI-BAFFR Mab) ADMINISTERED EVERY 4 WEEKS UP TO 48 WEEKS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Agmon-Levin N., Ignatenko S., Gordienko A.,Cortés-Hernández J.,Narongroeknawin P.,Romanowska -Prochnicka K.,Shen N.,Ciferská H., Kodera M.,Wei J.C.C.,Leszczynski P.,Lan J.L.,Mysler E.,Wojciechowski R.,Tarr T.,Vishneva E.,Chen Y.H., Kaneko Y.,Finzel S.,Hoi A.

Annals of the Rheumatic Diseases (2024): 140-142

引用0浏览0引用

Pattern Classification of Interstitial Lung Diseases from Computed Tomography Images Using a ResNet-based Network with a Split-Transform-merge Strategy and Split Attention

Jian-Xun Chen,Yu-Cheng Shen,Shin-Lei Peng,Yi-Wen Chen,Hsin-Yuan Fang,Joung-Liang Lan,Cheng-Ting Shih

Physical and Engineering Sciences in Medicine（2024）

引用0浏览0WOS引用

Safety and Efficacy of Subcutaneous Ianalumab (VAY736) for Up to 68 Weeks in Patients with Systemic Lupus Erythematosus: Results from Phase 2 Study

Eduardo Mysler, Stanislav Ignatenko, Alexander Gordienko,Josefina Cortes-Hernandez,Nancy Agmon-Levin,Pongthorn Narongroeknawin,Katarzyna Romanowska-Prochnicka,Nan Shen,Hana Ciferska,Masanari Kodera,James Cheng-Chung Wei,Piotr Leszczynski,Joung Liang Lan,Rafal Wojciechowski,Tunde Tarr, Elena Vishneva,Yi-Hsing Chen,Yuko Kaneko,Stephanie Finzel,Alberta Hoi,Masato Okada,Ajchara Koolvisoot,Shin-Seok Lee,Lie Dai,Hiroshi Kaneko,Bernadette Rojkovich,Lingyun Sun, Eugeny Zotkin,Jean-Francois Viallard, Berta Paula Magallares,Tirtha Sengupta,Carole Sips, Carole Lau,Alexandre Avrameas,Stephen J. Oliver

ARTHRITIS & RHEUMATOLOGY (2024): 5238-5240

引用0浏览0引用

Baseline ANA and Anti‐Ro60/SSA Antibody As Potential Predictors for Immunogenicity and Poor EULAR Response in Adalimumab‐Treated RA Patients

Yi-Ming Chen,Po-Ku Chen,Shih-Hsin Chang,Hsin-Hua Chen,Jun-Peng Chen,Kuo-Tung Tang,Joung-Liang Lan,Der-Yuan Chen

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2024)

引用0浏览0引用

Abatacept Retention and Clinical Effectiveness in Patients with Rheumatoid Arthritis in a Real‐world Setting in Taiwan

Kun‐Hung Chen,Ko‐Jen Li,Yao‐Fan Fang,Song‐Chou Hsieh,Ying‐Chou Chen, C. C. Lee, Shue‐Fen Luo,Tien‐Tsai Cheng, Wen‐Chan Tsai, Yuk‐Keung Lo,Joung‐Liang Lan

International Journal of Rheumatic Diseases（2024）

引用0浏览0引用

The Detectable Anti-Interferon-γ Autoantibodies in COVID-19 Patients May Be Associated with Disease Severity

Po-Ku Chen,Kai-Jieh Yeo,Shih-Hsin Chang,Tsai-Ling Liao,Chia-Hui Chou,Joung-Liang Lan,Ching-Kun Chang,Der-Yuan Chen

Virology Journal（2023）

引用7浏览0WOS引用

POS0120 SAFETY AND EFFICACY OF SUBCUTANEOUS (S.C.) DOSE IANALUMAB (VAY736; ANTI-BAFFR Mab) ADMINISTERED MONTHLY OVER 28 WEEKS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

J. Cortés-Hernández, S. Ignatenko, A. Gordienko,N. Agmon-Levin,P. Narongroeknawin,K. Romanowska -Prochnicka,N. Shen,H. Ciferská,M. Kodera,J.C.C. Wei,P. Leszczynski,J.L. Lan,R. Wojciechowski,T. Tarr,E. Vishneva,Y.H. Chen,Y. Kaneko,S. Finzel,A. Hoi,M. Okada

Annals of the Rheumatic Diseases (2023): 275-276

引用1浏览0引用

Lifetime Risk, Life Expectancy, Loss-of-life Expectancy, and Lifetime Healthcare Expenditures for Psoriasis in Taiwan: a Nationwide Cohort Followed from 2000 to 2017

Hsien-Yi Chiu,Joung-Liang Lan,Ying-Ming Chiu

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2023)

引用1浏览0WOS引用

Mirabegron is More Tolerable Than Solifenacin in Sjogren's Syndrome Patients with OAB

H. X. Chen, P. C. Wu,K. J. Yeo,S-H. Chang,J. L. Lan, P. H. Huang,C. M. Huang,C. P. Huang,D. Y. Chen,C-L. Chou

EUROPEAN UROLOGY（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn